As the U.S. stock market continues to rally, buoyed by President Trump's recent executive actions and a strong performance in major indices like the Dow Jones and S&P 500, investors are on the lookout for opportunities amid these shifting economic policies. In such an environment, identifying undervalued stocks can be crucial for those looking to capitalize on potential market inefficiencies, especially when certain equities are trading at significant discounts compared to their estimated intrinsic values. Top 10 Undervalued Stocks Based On Cash Flows In The United States Name Current Price Fair Value (Est) Discount (Est) Atlantic Union Bankshares (NYSE:AUB) $38.27 $75.53 49.3% First Solar (NasdaqGS:FSLR) $183.51 $357.85 48.7% Berkshire Hills Bancorp (NYSE:BHLB) $28.72 $56.94 49.6% German American Bancorp (NasdaqGS:GABC) $39.76 $78.06 49.1% Heartland Financial USA (NasdaqGS:HTLF) $66.48 $130.08 48.9% Equity Bancshares (NYSE:EQBK) $43.76 $85.93 49.1% Privia Health Group (NasdaqGS:PRVA) $22.73 $44.59 49% Verra Mobility (NasdaqCM:VRRM) $26.08 $52.02 49.9% Equifax (NYSE:EFX) $272.27 $534.41 49.1% Coeur Mining (NYSE:CDE) $6.37 $12.61 49.5% Click here to see the full list of 168 stocks from our Undervalued US Stocks Based On Cash Flows screener. Let's explore several standout options from the results in the screener. Rocket Lab USA Overview: Rocket Lab USA, Inc. is a space company offering launch services and space systems solutions for the space and defense industries, with a market cap of approximately $11.99 billion. Operations: The company's revenue is derived from two primary segments: Space Systems, contributing $272.33 million, and Launch Services, generating $91.49 million. Estimated Discount To Fair Value: 15.1% Rocket Lab USA is trading at US$31.27, below its estimated fair value of US$36.82, suggesting it may be undervalued based on cash flows. Despite significant insider selling and a volatile share price, the company is expected to achieve profitability within three years with revenue growth forecasted at 27% annually, surpassing market averages. Recent contracts with NASA and the U.S. Department of Defense highlight Rocket Lab's strategic positioning in the space industry as it expands its launch capabilities. Our comprehensive growth report raises the possibility that Rocket Lab USA is poised for substantial financial growth. Delve into the full analysis health report here for a deeper understanding of Rocket Lab USA.NasdaqCM:RKLB Discounted Cash Flow as at Jan 2025 Brinker International Overview: Brinker International, Inc. operates and franchises casual dining restaurants both in the United States and internationally, with a market cap of $6.40 billion. Story Continues Operations: Brinker International's revenue segments consist of $4.04 billion from Chili's and $500 million from Maggiano's. Estimated Discount To Fair Value: 41.8% Brinker International is trading at US$153.63, significantly below its estimated fair value of US$264.08, indicating potential undervaluation based on cash flows. The company has seen substantial earnings growth, with net income rising to US$38.5 million from US$7.2 million year-over-year in Q1 2024. Despite high debt levels and recent insider selling, Brinker forecasts robust annual profit growth of over 21%, although revenue growth lags behind market averages at 5.2%. Our earnings growth report unveils the potential for significant increases in Brinker International's future results. Unlock comprehensive insights into our analysis of Brinker International stock in this financial health report.NYSE:EAT Discounted Cash Flow as at Jan 2025 Equifax Overview: Equifax Inc. is a data, analytics, and technology company with a market capitalization of approximately $32.58 billion. Operations: The company's revenue is derived from three main segments: International at $1.34 billion, Workforce Solutions at $2.40 billion, and U.S. Information Solutions at $1.85 billion. Estimated Discount To Fair Value: 49.1% Equifax is trading at US$272.27, well below its estimated fair value of US$534.41, suggesting it might be undervalued based on cash flows. With earnings projected to grow significantly at 23.8% annually, surpassing the US market growth rate of 14.9%, Equifax shows strong potential despite high debt levels. Recent strategic moves include bolt-on acquisitions to bolster core operations and partnerships enhancing service offerings like The Work Number®, supporting robust cash flow generation and shareholder returns. The growth report we've compiled suggests that Equifax's future prospects could be on the up. Click to explore a detailed breakdown of our findings in Equifax's balance sheet health report.NYSE:EFX Discounted Cash Flow as at Jan 2025 Make It Happen Explore the 168 names from our Undervalued US Stocks Based On Cash Flows screener here. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqCM:RKLBNYSE:EAT and NYSE:EFX. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
3 US Stocks Trading At Estimated Discounts Of Up To 49.1%
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...